======= SMPD1 ======= == Gene Information == * **Official Symbol**: SMPD1 * **Official Name**: sphingomyelin phosphodiesterase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6609|6609]] * **UniProt**: [[https://www.uniprot.org/uniprot/P17405|P17405]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SMPD1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SMPD1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607608|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a lysosomal acid sphingomyelinase that converts sphingomyelin to ceramide. The encoded protein also has phospholipase C activity. Defects in this gene are a cause of Niemann-Pick disease type A (NPA) and Niemann-Pick disease type B (NPB). Multiple transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2010]. * **UniProt Summary**: Converts sphingomyelin to ceramide (PubMed:1840600, PubMed:18815062, PubMed:27659707, PubMed:25920558). Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol. {ECO:0000269|PubMed:1840600, ECO:0000269|PubMed:18815062, ECO:0000269|PubMed:25920558, ECO:0000269|PubMed:27659707, ECO:0000305}. Isoform 3 lacks residues that bind the cofactor Zn(2+) and has no enzyme activity. {ECO:0000269|PubMed:1840600, ECO:0000305}. |Metallophos| |acid sphingomyelin phosphodiesterase activity| |termination of signal transduction| |hydrolase activity, acting on glycosyl bonds| |sphingomyelin phosphodiesterase activity| |sphingomyelin catabolic process| |lamellar body| |phosphoric diester hydrolase activity| |sphingomyelin metabolic process| |sphingolipid catabolic process| |membrane lipid catabolic process| |phospholipid catabolic process| |positive regulation of protein dephosphorylation| |ceramide biosynthetic process| |response to cocaine| |positive regulation of dephosphorylation| |glycosphingolipid metabolic process| |negative regulation of MAP kinase activity| |response to anesthetic| |ceramide metabolic process| |sphingolipid biosynthetic process| |lysosomal lumen| |glycolipid metabolic process| |liposaccharide metabolic process| |response to alkaloid| |cholesterol metabolic process| |organophosphate catabolic process| |secondary alcohol metabolic process| |membrane lipid biosynthetic process| |negative regulation of protein serine/threonine kinase activity| |sterol metabolic process| |regulation of protein dephosphorylation| |sphingolipid metabolic process| |negative regulation of MAPK cascade| |response to ammonium ion| |ammonium ion metabolic process| |cellular lipid catabolic process| |membrane lipid metabolic process| |regulation of dephosphorylation| |negative regulation of protein kinase activity| |negative regulation of kinase activity| |lysosome| |steroid metabolic process| |endosome| |negative regulation of transferase activity| |lipid catabolic process| |response to xenobiotic stimulus| |alcohol metabolic process| |regulation of MAP kinase activity| |phospholipid metabolic process| |negative regulation of protein phosphorylation| |negative regulation of phosphorylation| |organic hydroxy compound metabolic process| |negative regulation of intracellular signal transduction| |regulation of protein serine/threonine kinase activity| |amide biosynthetic process| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |lipid biosynthetic process| |negative regulation of protein modification process| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of cell death| |regulation of MAPK cascade| |cellular amide metabolic process| |negative regulation of catalytic activity| |regulation of protein kinase activity| |zinc ion binding| |regulation of kinase activity| |organophosphate metabolic process| |response to organic cyclic compound| |cellular lipid metabolic process| |regulation of transferase activity| |response to organonitrogen compound| |response to drug| |carbohydrate derivative metabolic process| |negative regulation of cellular protein metabolic process| |organonitrogen compound catabolic process| |response to nitrogen compound| |negative regulation of protein metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |negative regulation of molecular function| |lipid metabolic process| |positive regulation of protein modification process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |organonitrogen compound biosynthetic process| |regulation of protein phosphorylation| |regulation of apoptotic process| |response to oxygen-containing compound| |regulation of programmed cell death| |regulation of phosphorylation| |extracellular space| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |cellular nitrogen compound biosynthetic process| |regulation of cell death| |positive regulation of protein metabolic process| |small molecule metabolic process| |organic substance catabolic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |cellular catabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-1.79| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6397 * **Expression level (log2 read counts)**: 0.47 {{:chemogenomics:nalm6 dist.png?nolink |}}